Periostin plays a critical role in the cell cycle in lung fibroblasts.
Cell cycle
Fibroblast
Idiopathic pulmonary fibrosis
Integrin
Periostin
Proliferation
Journal
Respiratory research
ISSN: 1465-993X
Titre abrégé: Respir Res
Pays: England
ID NLM: 101090633
Informations de publication
Date de publication:
30 Jan 2020
30 Jan 2020
Historique:
received:
29
07
2019
accepted:
19
01
2020
entrez:
1
2
2020
pubmed:
1
2
2020
medline:
24
11
2020
Statut:
epublish
Résumé
Idiopathic pulmonary fibrosis (IPF) is a devastating disease with a median survival of only three to 5 years. Fibroblast proliferation is a hallmark of IPF as is secretion of extracellular matrix proteins from fibroblasts. However, it is still uncertain how IPF fibroblasts acquire the ability to progressively proliferate. Periostin is a matricellular protein highly expressed in the lung tissues of IPF patients, playing a critical role in the pathogenesis of pulmonary fibrosis. However, it remains undetermined whether periostin affects lung fibroblast proliferation. In this study, we first aimed at identifying periostin-dependently expressed genes in lung fibroblasts using DNA microarrays. We then examined whether expression of cyclins and CDKs controlling cell cycle progression occur in a periostin-dependent manner. We next examined whether downregulation of cell proliferation-promoting genes by knockdown of periostin or integrin, a periostin receptor, using siRNA, is reflected in the cell proliferation of lung fibroblasts. We then looked at whether lung fibroblasts derived from IPF patients also require periostin for maximum proliferation. We finally investigated whether CP4715, a potent inhibitor against integrin α Many cell-cycle-related genes are involved in the upregulated or downregulated genes by periostin knockdown. We confirmed that in lung fibroblasts, periostin silencing downregulates expression of several cell-cycle-related molecules, including the cyclin, CDK, and, E2F families, as well as transcription factors such as B-MYB and FOXM1. Periostin or integrin silencing slowed proliferation of lung fibroblasts and periostin silencing increased the distribution of the G0/G1 phase, whereas the distribution of the G2/M phase was decreased. Lung fibroblasts derived from IPF patients also required periostin for maximum proliferation. Moreover, CP4715 downregulated proliferation along with expression of cell-cycle-related genes in IPF lung fibroblasts as well as in normal lung fibroblasts. Periostin plays a critical role in the proliferation of lung fibroblasts and the present results provide us a solid basis for considering inhibitors of the periostin/integrin α
Sections du résumé
BACKGROUND
BACKGROUND
Idiopathic pulmonary fibrosis (IPF) is a devastating disease with a median survival of only three to 5 years. Fibroblast proliferation is a hallmark of IPF as is secretion of extracellular matrix proteins from fibroblasts. However, it is still uncertain how IPF fibroblasts acquire the ability to progressively proliferate. Periostin is a matricellular protein highly expressed in the lung tissues of IPF patients, playing a critical role in the pathogenesis of pulmonary fibrosis. However, it remains undetermined whether periostin affects lung fibroblast proliferation.
METHODS
METHODS
In this study, we first aimed at identifying periostin-dependently expressed genes in lung fibroblasts using DNA microarrays. We then examined whether expression of cyclins and CDKs controlling cell cycle progression occur in a periostin-dependent manner. We next examined whether downregulation of cell proliferation-promoting genes by knockdown of periostin or integrin, a periostin receptor, using siRNA, is reflected in the cell proliferation of lung fibroblasts. We then looked at whether lung fibroblasts derived from IPF patients also require periostin for maximum proliferation. We finally investigated whether CP4715, a potent inhibitor against integrin α
RESULTS
RESULTS
Many cell-cycle-related genes are involved in the upregulated or downregulated genes by periostin knockdown. We confirmed that in lung fibroblasts, periostin silencing downregulates expression of several cell-cycle-related molecules, including the cyclin, CDK, and, E2F families, as well as transcription factors such as B-MYB and FOXM1. Periostin or integrin silencing slowed proliferation of lung fibroblasts and periostin silencing increased the distribution of the G0/G1 phase, whereas the distribution of the G2/M phase was decreased. Lung fibroblasts derived from IPF patients also required periostin for maximum proliferation. Moreover, CP4715 downregulated proliferation along with expression of cell-cycle-related genes in IPF lung fibroblasts as well as in normal lung fibroblasts.
CONCLUSIONS
CONCLUSIONS
Periostin plays a critical role in the proliferation of lung fibroblasts and the present results provide us a solid basis for considering inhibitors of the periostin/integrin α
Identifiants
pubmed: 32000779
doi: 10.1186/s12931-020-1299-0
pii: 10.1186/s12931-020-1299-0
pmc: PMC6993476
doi:
Substances chimiques
Cell Adhesion Molecules
0
POSTN protein, human
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
38Subventions
Organisme : Japan Society for the Promotion of Science
ID : #JP16H05343
Références
Mol Cell Biol. 2004 May;24(9):3992-4003
pubmed: 15082792
Circ Res. 2009 Jan 2;104(1):e1-7
pubmed: 19038863
Cell Mol Life Sci. 2003 Nov;60(11):2389-401
pubmed: 14625684
Wiley Interdiscip Rev Syst Biol Med. 2016 Mar-Apr;8(2):140-56
pubmed: 26613368
J Allergy Clin Immunol. 2006 Jul;118(1):98-104
pubmed: 16815144
Bioorg Med Chem. 2006 Apr 1;14(7):2109-30
pubmed: 16309912
Crit Rev Biochem Mol Biol. 2017 Dec;52(6):638-662
pubmed: 28799433
Cancer Res. 2010 Jul 1;70(13):5281-92
pubmed: 20516120
Respir Res. 2018 Aug 15;19(1):153
pubmed: 30111332
Am J Pathol. 2014 Mar;184(3):859-70
pubmed: 24418260
Am J Physiol Lung Cell Mol Physiol. 2012 Dec 15;303(12):L1046-56
pubmed: 23043074
Respir Res. 2017 Jan 5;18(1):3
pubmed: 28057004
Am J Respir Cell Mol Biol. 2009 Nov;41(5):583-9
pubmed: 19251946
Mol Biol Rep. 2010 Jun;37(5):2285-93
pubmed: 19688273
Front Oncol. 2018 Jun 12;8:225
pubmed: 29946533
Bioorg Med Chem. 2006 Apr 1;14(7):2089-108
pubmed: 16309911
Am J Pathol. 2005 Feb;166(2):399-407
pubmed: 15681824
EMBO Mol Med. 2018 Feb;10(2):276-293
pubmed: 29217661
Matrix Biol. 2014 Feb;34:144-53
pubmed: 24184828
Am J Respir Crit Care Med. 2013 Jul 15;188(2):133-40
pubmed: 23306542
Pigment Cell Melanoma Res. 2014 Jul;27(4):630-9
pubmed: 24674392
Nat Rev Dis Primers. 2017 Oct 20;3:17074
pubmed: 29052582
Eur Respir J. 2011 May;37(5):1119-27
pubmed: 21177844
J Clin Invest. 2012 Jul;122(7):2590-600
pubmed: 22684102
J Biol Chem. 2018 Sep 21;293(38):14646-14658
pubmed: 30076218
J Exp Med. 2008 Jul 7;205(7):1659-72
pubmed: 18541712
Am J Respir Cell Mol Biol. 2020 Feb;62(2):204-216
pubmed: 31505128
Carcinogenesis. 2005 May;26(5):908-15
pubmed: 15731169
Cell Prolif. 2003 Jun;36(3):131-49
pubmed: 12814430
PLoS One. 2014 Mar 19;9(3):e92111
pubmed: 24647608
Arthritis Rheum. 2011 Mar;63(3):783-94
pubmed: 21360508
Allergol Int. 2014 Jun;63(2):143-51
pubmed: 24662806
Nat Med. 2007 Aug;13(8):962-9
pubmed: 17632525
Bioorg Med Chem. 2006 Apr 1;14(7):2131-50
pubmed: 16307881
J Cell Sci. 2001 Jul;114(Pt 14):2553-60
pubmed: 11683383
Bioorg Med Chem. 2006 Jun 15;14(12):4158-81
pubmed: 16504518
Cell Mol Life Sci. 2017 Dec;74(23):4293-4303
pubmed: 28887633
J Thorac Dis. 2018 Jul;10(7):E587-E591
pubmed: 30174940
Curr Opin Cell Biol. 2007 Dec;19(6):649-57
pubmed: 18032011
Development. 2013 Aug;140(15):3079-93
pubmed: 23861057
Am J Respir Cell Mol Biol. 2012 May;46(5):677-86
pubmed: 22246863